<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>MUN Sources practice by Jonathan David Delgado</title>
      <link>https://padlet.com/jonathan_delgado1/mffxuoy4pe9w</link>
      <description>Made with swagger</description>
      <language>en-us</language>
      <pubDate>2018-01-17 21:19:26 UTC</pubDate>
      <lastBuildDate>2026-03-19 20:14:49 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet-assets.s3.amazonaws.com/icons/Growing.png</url>
      </image>
      <item>
         <title>Solution for corruption</title>
         <author>suhyeon_w_3012</author>
         <link>https://padlet.com/jonathan_delgado1/mffxuoy4pe9w/wish/222250696</link>
         <description><![CDATA[<div>Civil society is preparing for the United Nations General Assembly Special Session (UNGASS) on the world drug problem in 2016. On 3 December 2014, before an audience of Member States representatives, UN experts, fellow NGOs and students, the Civil Society Task Force -  CSTF was launched. The launch was co-sponsored by the Permanent Missions of Italy, Mexico, Norway, Sweden and the United States of America. The event was chaired by H.E. Ambassador Bente Angell-Hansen, Permanent Representative of the Kingdom of Norway to the International Organizations in Vienna, who welcomed the creation of the CSTF.<br>Building on the success of <a href="http://vngoc.org/details.php?id_cat=8&amp;id_cnt=56">Beyond 2008</a>, the CSTF is a joint initiative of the Vienna NGO Committee on Drugs - <a href="http://vngoc.org/">VNGOC</a> and the New York Committee on Drugs - <a href="http://nyngoc.org/">NYNGOC</a>. The CSTF will act as official liaison between the United Nations and civil society in the preparatory process of and at the <a href="http://www.unodc.org/ungass2016/">UNGASS 2016</a>. The newly created body will seek to ensure a comprehensive, structured, meaningful and balanced participation of civil society during this process.  Mr. Esbjörn Hörnberg, Chairperson, VNGOC and Ms. Elisa Rubini, Vice-Chairperson, VNGOC elaborated on the added value of the CSTF, its structure and roadmap of activities until UNGASS 2016. Ms. Heather Haase, Chairperson, NYNGOC and Mr. Allan Clear, Treasurer, NYNGOC, drew attention to the role NGOs would play in the UNGASS 2016 preparatory process, as well as the framework for civil society engagement in this process. Mr. Aldo Lale-Demoz, UNODC Deputy Executive Director, congratulated the two Committees on their joint initiative and indicated that UNODC stood ready to work with the two Committees in the preparatory process for UNGASS 2016. Ambassador Khaled Shamaa, Chairperson of the 57th session of the Commission on Narcotic Drugs, wished the CSTF a successful start and encouraged NGOs working on the ground to share their experience on which drug policies work and which do not. In her presentation, Ms. Mirella Dummar Frahi, UNODC Civil Society Team Leader, showed a <a href="https://www.unodc.org/documents/NGO/2014-12-09_Drug_NGOs_recommended_by_FOs.pdf">graph</a> including an overview of NGOs working on drug related issues on the ground recommended by the UNODC Field Offices and referred to the results of the <a href="https://www.unodc.org/documents/NGO/Beyond_2008_Evaluation_FINAL_August_2009.pdf">independent evaluation</a> of Beyond 2008.A lively questions and answers session followed, during which speakers called for active civil society participation in a more interactive and substantive preparatory process for UNGASS 2016. </div><div><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2018-01-17 21:44:54 UTC</pubDate>
         <guid>https://padlet.com/jonathan_delgado1/mffxuoy4pe9w/wish/222250696</guid>
      </item>
      <item>
         <title></title>
         <author></author>
         <link>https://padlet.com/jonathan_delgado1/mffxuoy4pe9w/wish/222250885</link>
         <description><![CDATA[<div>Topic: FLU EPIDEMIC</div><div><br></div><div>Who? The article was wrote by a reporter called Richard Hartley Parkinson.</div><div><br></div><div>What? The article is about a notice of a 9 years old girl that die dies from new eye-bleeding fever more dangerous than the Black Death.</div><div><br></div><div>Where? The location of the notice is in Nakaseke District, central Uganda.</div><div><br></div><div>When? The article was wrote in Jan 15, 2018.</div><div><br></div><div>Why? The girl die because she had a new eye bleeding fever.</div><div><br></div><div>How? Her death has sparked fears of a major health crisis in East Africa that could spread significantly.</div><div><br></div><div>How many? The Black Death killed between 75 and 200 million people between 1346 and 1353.</div><div><br></div><div>Interesting facts: An interesting fact is that if the Black Death killed around 75-200 millions, imagine how many people do this disease can kill if it is more dangerous that the Black Death. This disease can kill around 100-350 million of people if it is not stop it.</div><div><br></div><div>Solution: My committee solutions are: the government to pay to some scientists to find first what cause it and some permanent or temporary preventions, like vaccines and shots medicine. Although this disease can be treated with antibiotics and has largely disappeared in Western countries, we can to be treated in poor zones Iike Africa &amp; India. To make a campaign to recollect funds to provide poor zones people to live in a clean and health place and to maintain them eating healthy, so the disease do not control or manipulates the immune system so easily.</div>]]></description>
         <enclosure url="" />
         <pubDate>2018-01-17 21:45:55 UTC</pubDate>
         <guid>https://padlet.com/jonathan_delgado1/mffxuoy4pe9w/wish/222250885</guid>
      </item>
      <item>
         <title>Unethical human experimentation </title>
         <author></author>
         <link>https://padlet.com/jonathan_delgado1/mffxuoy4pe9w/wish/222251010</link>
         <description><![CDATA[<ul><li><a href="https://wyss.harvard.edu/">Harvard’s Wyss Institute</a> has created <a href="https://wyss.harvard.edu/viewpage/461/">“organs-on-chips”</a> that contain human cells grown in a state-of-the-art system to mimic the structure and function of human organs and organ systems. The chips can be used instead of animals in disease research, drug testing, and toxicity testing and have <a href="https://wyss.harvard.edu/viewpressrelease/99">been shown</a> to replicate human physiology, diseases, and drug responses more accurately than crude animal experiments do. Some companies, such as the <a href="http://hurelcorp.com/technology/">HµRel Corporation</a>, have already turned these chips into products that other researchers can use in place of animals.</li><li>Strikingly life-like computerized <a href="http://www.caehealthcare.com/eng/patient-simulators/istan">human-patient simulators</a> that breathe, bleed, convulse, talk, and even “die” have been <a href="http://www.bioscience.heacademy.ac.uk/ftp/events/sltc09/presentations/o29maskell.pdf">shown</a> to teach students physiology and pharmacology better than crude exercises that involve cutting up animals. The most high-tech simulators mimic illnesses and injuries and give the appropriate biological response to medical interventions and injections of medications. Ninety-seven percent of medical schools across the U.S. have <a href="https://www.pcrm.org/research/edtraining/meded/medical-schools-with-no-live-animal-laboratories">completely replaced</a> the use of animal laboratories in medical training with simulators like this, as well as virtual-reality systems, <a href="http://www.teachkind.org/dissectalt.asp">computer simulators</a>, and supervised clinical experience.</li></ul><div><br></div>]]></description>
         <enclosure url="" />
         <pubDate>2018-01-17 21:46:33 UTC</pubDate>
         <guid>https://padlet.com/jonathan_delgado1/mffxuoy4pe9w/wish/222251010</guid>
      </item>
   </channel>
</rss>
